Metformin attenuates experimental autoimmune arthritis through reciprocal regulation of Th17/Treg balance and osteoclastogenesis

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Son, Hye Jin ^a,b   Lee, Jennifer ^b   Lee, Seon Yeong ^a,b   Kim, Eun Kyung ^a,b   Park, Min Jung ^a,b   Kim, Kyoung Woon ^a,c   Park, Sung Hwan ^b   Cho, Mi La ^a,b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Konkuk University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; MAMMALIAN TARGET OF RAPAMYCIN; METFORMIN; STAT3 PROTEIN; STAT5 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL POPULATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SPLEEN; TH17 CELL; UPREGULATION; ANIMAL; C57BL MOUSE; DRUG EFFECT; EXPERIMENTAL ARTHRITIS; IMMUNOLOGY; METABOLISM; OSTEOCLAST;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELL DIFFERENTIATION; INTERLEUKIN-17; MALE; METFORMIN; MICE; MICE, INBRED C57BL; OSTEOCLASTS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84907228811     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/973986     Document Type: Article

References (25)

1. Feldmann M., Brennan F. M., Maini R. N., Rheumatoid arthritis. Cell 1996 85 3 307 310 10.1016/S0092-8674(00)81109-5 2-s2.0-0030003058
2. McInnes I. B., Schett G., The pathogenesis of rheumatoid arthritis. The New England Journal of Medicine 2011 365 23 2205 2219 10.1056/NEJMra1004965 2-s2.0-84855172814
3. Lee Y. K., Mukasa R., Hatton R. D., Weaver C. T., Developmental plasticity of Th17 and Treg cells. Current Opinion in Immunology 2009 21 3 274 280 10.1016/j.coi.2009.05.021 2-s2.0-67049097104
4. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M. F., Goodyear L. J., Moller D. E., Role of AMP-activated protein kinase in mechanism of metformin action. The Journal of Clinical Investigation 2001 108 8 1167 1174 10.1172/JCI200113505 2-s2.0-0034773404
5. Rena G., Pearson E. R., Sakamoto K., Molecular mechanism of action of metformin: old or new insights? Diabetologia 2013 56 9 1898 1906 10.1007/s00125-013-2991-0 2-s2.0-84881614717
6. Kahn B. B., Alquier T., Carling D., Hardie D. G., AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metabolism 2005 1 1 15 25 10.1016/j.cmet.2004.12.003 2-s2.0-20844451123
7. Nagai S., Kurebayashi Y., Koyasu S., Role of PI3K/Akt and mTOR complexes in Th17 cell differentiation. Annals of the New York Academy of Sciences 2013 1280 1 30 34 10.1111/nyas.12059 2-s2.0-84875661336
8. Gravallese E. M., Harada Y., Wang J. T., Gorn A. H., Thornhill T. S., Goldring S. R., Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. The American Journal of Pathology 1998 152 4 943 951 2-s2.0-0031894140
9. Glantschnig H., Fisher J. E., Wesolowski G., Rodan G. A., Reszka A. A., M-CSF, TNF α and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase. Cell Death and Differentiation 2003 10 10 1165 1177 10.1038/sj.cdd.4401285 2-s2.0-0141893375
10. Indo Y., Takeshita S., Ishii KA., Metabolic regulation of osteoclast differentiation and function. Journal of Bone and Mineral Research 2013 28 2392 2399
11. Williams R. O., Feldmann M., Maini R. N., Anti-tumor necrosis factor ameliorates joint disease in murine collagen- induced arthritis. Proceedings of the National Academy of Sciences of the United States of America 1992 89 20 9784 9788 10.1073/pnas.89.20.9784 2-s2.0-0026644298
12. +T cells in collagen-induced arthritis. Immunology Letters 2008 117 1 16 25 10.1016/j.imlet.2007.09.011 2-s2.0-40649110475
13. Camps M., Rückle T., Ji H., Ardissone V., Rintelen F., Shaw J., Ferrandi C., Chabert C., Gillieron C., Françon B., Martin T., Gretener D., Perrin D., Leroy D., Vitte P., Hirsch E., Wymann M. P., Cirillo R., Schwarz M. K., Rommel C., Blockade of PI3K γ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nature Medicine 2005 11 9 936 943 10.1038/nm1284 2-s2.0-24744435115
14. Park J., Park M., Oh H., Woo Y., Lim M., Lee J., Ju J. H., Jung Y. O., Lee Z. H., Park S., Kim H., Cho M., Min J., Grape-seed proanthocyanidin extract as suppressors of bone destruction in inflammatory autoimmune arthritis. PLoS ONE 2012 7 12 e51377 10.1371/journal.pone.0051377 2-s2.0-84870906320
15. +regulatory T cells. Proceedings of the National Academy of Sciences of the United States of America 2008 105 47 18460 18465 10.1073/pnas.0809850105 2-s2.0-57449112782
16. Hanidziar D., Koulmanda M., Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance. Current Opinion in Organ Transplantation 2010 15 4 411 415 10.1097/MOT.0b013e32833b7929 2-s2.0-77955230058
17. Kang K. Y., Kim Y. K., Yi H., Kim J., Jung H., Kim I. J., Cho J., Park S., Kim H., Ju J. H., Metformin downregulates Th17 cells differentiation and attenuates murine autoimmune arthritis. International Immunopharmacology 2013 16 1 85 92 10.1016/j.intimp.2013.03.020 2-s2.0-84875999344
18. +T cell subsets. Journal of Immunology 2011 186 6 3299 3303 10.4049/jimmunol.1003613 2-s2.0-79953172571
19. Shi L. Z., Wang R., Huang G., Vogel P., Neale G., Green D. R., Chi H., HIF1 α -dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. Journal of Experimental Medicine 2011 208 7 1367 1376 10.1084/jem.20110278 2-s2.0-79960369458
20. Dang E. V., Barbi J., Yang H., Jinasena D., Yu H., Zheng Y., Bordman Z., Fu J., Kim Y., Yen H., Luo W., Zeller K., Shimoda L., Topalian S. L., Semenza G. L., Dang C. V., Pardoll D. M., Pan F., Control of TH17/Treg balance by hypoxia-inducible factor 1. Cell 2011 146 5 772 784 10.1016/j.cell.2011.07.033 2-s2.0-80052277906
21. Nerstedt A., Johansson A., Andersson C. X., Cansby E., Smith U., Mahlapuu M., AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3). Diabetologia 2010 53 11 2406 2416 10.1007/s00125-010-1856-z 2-s2.0-77957653461
22. Yang X. P., Ghoreschi K., Steward-Tharp S. M., Rodriguez-Canales J., Zhu J., Grainger J. R., Hirahara K., Sun H., Wei L., Vahedi G., Kanno Y., O'Shea J. J., Laurence A., Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nature Immunology 2011 12 3 247 254 10.1038/ni.1995 2-s2.0-79951682333
23. Nath N., Khan M., Paintlia M. K., Singh I., Hoda M. N., Giri S., Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. The Journal of Immunology 2009 182 12 8005 8014 10.4049/jimmunol.0990060 2-s2.0-77953643439
24. Mai Q., Zhang Z., Xu S., Lu M., Zhou R., Zhao L., Jia C., Wen Z., Jin D., Bai X., Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. Journal of Cellular Biochemistry 2011 112 10 2902 2909 10.1002/jcb.23206 2-s2.0-80053186807
25. Kang H., Viollet B., Wu D., Genetic deletion of catalytic subunits of AMP-activated protein kinase increases osteoclasts and reduces bone mass in young adult mice. The Journal of Biological Chemistry 2013 288 17 12187 12196 10.1074/jbc.M112.430389 2-s2.0-84876944006